MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.
Issue link: https://medesthetics.epubxp.com/i/238490
NEWS & EVENTS IN MEMORIAM Skincare pioneer Pierre Fabre, founder and president of Pierre Fabre Laboratories, passed away on July 20, 2013, at the age of 87. As one of France's greatest entrepreneurs, Fabre left a nation in mourning. French President F was constantly in advance of his time, never ceasing to PIERRE FABRE innovate, invent, invest." A pharmacist by training, Fabre purchased a pharmacy in Castres, France, in 1951. When he created Pierre Fabre Laboratories in 1961, Fabre said his mission was to "take care of the human being in his wholeness and diversity." He stayed true to that mission, as the company eventually grew into the third largest French pharmaceutical company, encompassing brands like Avéne, Furterer and Klorane. Headquartered in the city of Castres in the Southwest of France, Pierre Fabre Laboratories has branches in 42 countries and employs 10,000 people— providing significant employment to the Castres region. Fabre was also a rugby aficionado, and in 1989 he bought Castres Olympique, a French rugby union based in the same city as the Laboratories. During his time at the team's owner, Castres won two French championship titles, in 1993 and 2013. Fabre is survived by his nephews. SYNERON AND UNILEVER JOIN FORCES IN HOME BEAUTY DEVICE MARKET Syneron Medical, a developer of aesthetic medical devices, and Unilever Ventures, the venture capital and private equity arm of Unilever, have entered into a definitive agreement to form a joint venture in home beauty devices under the name Iluminage Beauty. The goal of the partnership is to develop and bring to the consumer market innovative, high performance, professional level devices for at-home use by leveraging Unilever's global experience in the development and marketing of consumer beauty products and Syneron Medical's expertise in professional aesthetic device technology. Under the terms of the agreement, Unilever will invest $25 million and sell and transfer its luxury beauty subsidiary Iluminage to the joint venture, while Syneron Medical will sell and transfer its Syneron Beauty subsidiary and related home-use businesses to the joint venture, creating Iluminage Beauty. Unilever Ventures will hold 51% of Iluminage Beauty and Syneron Medical will retain the remaining 49%. "Unilever is an ideal partner with consumer brand experience and significant global resources. We believe this joint venture represents the best opportunity to maximize our investment in Syneron Beauty and benefit from its growth 54 JANUARY/FEBRUARY 2014 | MedEsthetics potential as part of Iluminage Beauty, while also enabling Syneron Medical to focus resources on its professional aesthetic devices business," said Shimon Eckhouse, CEO of Syneron Medical. "The combined Iluminage Beauty business will be well positioned to gain share in the global market, which will build value for our shareholders." CYNOSURE EXPANDS WITH INTERNATIONAL REGULATORY APPROVALS Cynosure has been granted marketing clearance from Australia's Therapeutic Goods Administration for the PicoSure Picosecond Laser for the removal of tattoos and benign pigmented lesions. The PicoSure was introduced in the United States in 2013 after receiving clearance from the U.S. Food and Drug Administration. The product is also being marketed in the European Union and Canada. Cynosure also received approval from the China Food and Drug Administration to market the Smartlipo MPX LaserBodySculpting Workstation, a laser-assisted lipolysis system designed to disrupt fat cells and tighten tissue through tissue coagulation. In addition, the PinPointe FootLaser, which Cynosure distributes through an exclusive worldwide agreement with NuvoLase, has been cleared by the Korean Ministry of Food and Drug Safety for the treatment of onychomycosis. "Further expanding our international product reach is an important part of our long-term growth strategy," said Michael Davin, president and CEO of Cynosure. "International markets generate nearly half of our total laser revenue. Our goal is to continue to enhance our presence in high-growth regions by capitalizing on our outstanding brand reputation, broad distribution capabilities and strong customer relationships. With our innovative laser treatments rapidly gaining in popularity and accessibility around the world, Cynosure is playing an integral role in driving the growth of the global aesthetic market." ULTHERA LAUNCHES SYSTEM UPGRADE Ulthera has launched a new software upgrade, Ultherapy Amplify, for its Ulthera ultrasound-assisted skin tightening system. Ultherapy Amplify integrates new treatment guidelines for the system's cosmetic lifting procedure to improve patient comfort without impacting efficacy, and to reflect treatment best practices. Also included is a more visual, intuitive userinterface, which allows practitioners to navigate through the procedure more efficiently. The upgrade is currently being rolled out to existing Ulthera customers at no charge. "This is a significant enhancement that reflects our continued commitment to responding to the needs of our physician customers and their patients," said Matthew Likens, president and CEO of Ulthera. "We are happy to say that Ultherapy Amplify addresses the critical factors of comfort, efficiency and